InvestSMART

Immuron Limited (ASX: IMC) - Announcements

- Current share price for IMC : $0.046

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immuron Limited (IMC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$15 CEO to Present on US Investor TV Show and at Biotech Conf 10 Jan 2018 10:35AM $0.200 $0.046 fallen by 77%
$15 Form 604 - Change in Substantial Shareholding (Grandlodge) 22 Dec 2017 6:36PM $0.170 $0.046 fallen by 72.94%
$15 Appendix 3Y - Change of Director's Interest Notice (SA) 22 Dec 2017 6:36PM $0.170 $0.046 fallen by 72.94%
$15 Appendix 3Y - Change of Director's Interest Notice (PA) 22 Dec 2017 6:33PM $0.170 $0.046 fallen by 72.94%
$15 Appendix 3B 14 Dec 2017 2:55PM $0.170 $0.046 fallen by 72.94%
$15 Van Leeuwenhoeck Institute Updates Immuron Research Coverage 22 Nov 2017 12:35PM $0.180 $0.046 fallen by 74.44%
$15 Immuron Granted US Patent for NASH Treatment 14 Nov 2017 10:03AM $0.180 $0.046 fallen by 74.44%
$15 Results of 2017 Annual General Meeting 13 Nov 2017 6:34PM $0.180 $0.046 fallen by 74.44%
$15 Immuron Successfully Completes NASH Phase II Clinical Study 9 Nov 2017 9:54AM $0.205 $0.046 fallen by 77.56%
$15 Travelan Experiences Strong Q1 FY2018 Sales Growth 8 Nov 2017 3:00PM $0.185 $0.046 fallen by 75.14%
$15 Immuron Lodges Form 20F USA Annual Report 3 Nov 2017 12:25PM $0.180 $0.046 fallen by 74.44%
$15 Notice of Annual General Meeting & Proxy Form 18 Oct 2017 2:18PM $0.155 $0.046 fallen by 70.32%
$15 Appendix 3Y - Change of Director's Interest Notice (PA) 10 Oct 2017 10:05AM $0.165 $0.046 fallen by 72.12%
$15 Corporate Governance Statement 28 Sep 2017 5:20PM $0.170 $0.046 fallen by 72.94%
$15 Appendix 4G 28 Sep 2017 5:20PM $0.170 $0.046 fallen by 72.94%
$15 Annual Report 28 Sep 2017 5:19PM $0.170 $0.046 fallen by 72.94%
$15 Appendix 3Y - Change of Director's Interest Notice (DP) 11 Sep 2017 9:58AM $0.185 $0.046 fallen by 75.14%
$15 Form 605 - Ceasing to be Substantial Shareholder (Retzos) 8 Sep 2017 4:57PM $0.185 $0.046 fallen by 75.14%
$15 Appendix 4E Preliminary Final Report (30 June 2017) 31 Aug 2017 3:23PM $0.200 $0.046 fallen by 77%
$15 Immuron Opens Clinical Site to Commence C.Diff CDI Study 28 Aug 2017 9:57AM $0.205 $0.046 fallen by 77.56%
$15 Appendix 3Y - Change of Director's Interest Notice (PA) 28 Aug 2017 8:16AM $0.205 $0.046 fallen by 77.56%
$15 Updated Immuron Securities Trading Policy 17 Aug 2017 3:08PM $0.205 $0.046 fallen by 77.56%
$15 Appendix 3Y - Change of Director's Interest Notice (PA) 15 Aug 2017 4:17PM $0.195 $0.046 fallen by 76.41%
$15 Immuron Commences US Non-Deal Institutional Investor Roadshw 15 Aug 2017 2:42PM $0.180 $0.046 fallen by 74.44%
$15 Immuron Approved to Commence Clinical Study in C.Difficile 9 Aug 2017 9:52AM $0.180 $0.046 fallen by 74.44%

526 - 550 of 782 results

Page 22 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.